Old Web
English
Sign In
Acemap
>
Paper
>
P1.01-018 Acquired Resistance to Crizotinib in Advanced NSCLC with De Novo MET Overexpression
P1.01-018 Acquired Resistance to Crizotinib in Advanced NSCLC with De Novo MET Overexpression
2017
A. Li
J. Yang
X. Zhang
Jian-Su
Qinghua Zhou
H. Chen
Zhi Xie
H. Tu
Wen-Zhao Zhong
Zhongtang Wang
C. Xu
Z. Chen
Hong-Hong Yan
Y. Wu
Keywords:
Pathology
Crizotinib
Medicine
Internal medicine
Oncology
acquired resistance
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]